VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
GE HealthCare Technologies Inc. vs Gilead Sciences, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
GE HealthCare Technologies Inc.
GEHC · The Nasdaq Stock Market LLC
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into GE HealthCare Technologies Inc.'s moat claims, evidence, and risks.
View GEHC analysisGilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisComparison highlights
- Moat score gap: Gilead Sciences, Inc. leads (74 / 100 vs 63 / 100 for GE HealthCare Technologies Inc.).
- Segment focus: GE HealthCare Technologies Inc. has 4 segments (45% in Imaging); Gilead Sciences, Inc. has 5 segments (68.5% in HIV).
- Moat breadth: GE HealthCare Technologies Inc. has 8 moat types across 4 domains; Gilead Sciences, Inc. has 8 across 3.
Primary market context
GE HealthCare Technologies Inc.
Imaging
Diagnostic imaging equipment and related service (CT, MR, molecular imaging, X-ray, women's health) and imaging IT
Global
Hospitals, imaging centers
OEM + service + software
45%
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
Side-by-side metrics
Moat coverage
Shared moat types
GE HealthCare Technologies Inc. strengths
Gilead Sciences, Inc. strengths
Segment mix
GE HealthCare Technologies Inc. segments
Full profile >Imaging
Oligopoly
Advanced Visualization Solutions (AVS)
Oligopoly
Patient Care Solutions (PCS)
Oligopoly
Pharmaceutical Diagnostics (PDx)
Oligopoly
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.